(Q46699519)

24 December 2017

title

Tissue inhibitor of metalloproteinases levels in patients with chronic heart failure: an independent predictor of mortality (English)

1 reference

24 December 2017

main subject

heart failure

0 references

patient

0 references

chronic heart failure

1 reference

S Frantz

1

1 reference

24 December 2017

S Störk

2

1 reference

24 December 2017

K Michels

3

1 reference

24 December 2017

M Eigenthaler

4

1 reference

24 December 2017

G Ertl

5

1 reference

24 December 2017

J Bauersachs

6

1 reference

24 December 2017

C E Angermann

7

1 reference

24 December 2017

publication date

17 March 2008

1 reference

24 December 2017

European Journal of Heart Failure

published in

1 reference

24 December 2017

volume

10

1 reference

24 December 2017

issue

4

1 reference

24 December 2017

page(s)

388-395

1 reference

24 December 2017

Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.02.015

Relations of plasma matrix metalloproteinase-9 to clinical cardiovascular risk factors and echocardiographic left ventricular measures: the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.02.015

Circulating level of gelatinase activity predicts ventricular remodeling in patients with acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.02.015

Plasma MMP-9 and MMP-2 following acute myocardial infarction in man: correlation with echocardiographic and neurohumoral parameters of left ventricular dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.02.015

Matrix metalloproteinase-9 is a marker of heart failure after acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.02.015

N-terminal pro-B-type natriuretic peptide and matrix metalloproteinases in early and late left ventricular remodeling after acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.02.015

Matrix metalloproteinase-1 and its inhibitor, TIMP-1, in systolic heart failure: relation to functional data and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.02.015

Prognostic value of tissue inhibitor of metalloproteinase-1 for cardiovascular death among patients with cardiovascular disease: results from the AtheroGene study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.02.015

Diastolic heart failure: evidence of increased myocardial collagen turnover linked to diastolic dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.02.015

Increased circulating matrix metalloproteinase-2 in patients with hypertrophic cardiomyopathy with systolic dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.02.015

The relationship between aldosterone, oxidative stress, and inflammation in chronic, stable human heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.02.015

Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.02.015

The meaning and use of the area under a receiver operating characteristic (ROC) curve

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.02.015

A method of comparing the areas under receiver operating characteristic curves derived from the same cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.02.015

Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.02.015

Downregulation of matrix metalloproteinases and reduction in collagen damage in the failing human heart after support with left ventricular assist devices

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.02.015

Regulation of matrix metalloproteinases by cytokines and reactive oxygen/nitrogen species in the myocardium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.02.015

Oxidized low-density lipoprotein regulates matrix metalloproteinase-9 and its tissue inhibitor in human monocyte-derived macrophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.02.015

Neurohormonal activation is associated with increased levels of plasma matrix metalloproteinase-2 in human heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.02.015

Serum levels of matrix metalloproteinases and tumor necrosis factor-alpha in patients with idiopathic dilated cardiomyopathy and effect of carvedilol on these levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.02.015

Metalloproteinases 2 and 9 are increased in plasma of patients with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.02.015

Plasma matrix metalloproteinase and inhibitor profiles in patients with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.02.015

10.1016/J.EJHEART.2008.02.015

21 January 2018

Identifiers

DOI

1 reference

24 December 2017

1 reference

24 December 2017